Viracta Therapeutics Inc (VIRX)
0.2003
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
0.2003
0.00 (0.00%)
After-Hours: 18:56
Viracta Therapeutics Total Liabilities (Quarterly): 28.65M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 28.65M |
| March 31, 2024 | 30.25M |
| December 31, 2023 | 38.37M |
| September 30, 2023 | 36.43M |
| June 30, 2023 | 36.08M |
| March 31, 2023 | 34.67M |
| December 31, 2022 | 34.89M |
| September 30, 2022 | 14.39M |
| Date | Value |
|---|---|
| June 30, 2022 | 12.15M |
| March 31, 2022 | 12.78M |
| December 31, 2021 | 14.18M |
| September 30, 2021 | 12.56M |
| June 30, 2021 | 11.58M |
| March 31, 2021 | 11.46M |
| December 31, 2020 | 94.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.46M
Minimum
Mar 2021
94.50M
Maximum
Dec 2020
28.20M
Average
28.65M
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 37.59M |
| GlycoMimetics Inc | 4.356M |
| FibroGen Inc | 483.58M |
| Cidara Therapeutics Inc | 42.42M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.32M |
| Shareholders Equity (Quarterly) | 2.671M |